The approximate plasma publicity to methylphenidate as well as its most important metabolite PPAA in pregnant rats was 1–two situations that seen in trials in volunteers and individuals with the maximum encouraged dose of CONCERTA according to the AUC. The protection of methylphenidate to be used during human pregnancy has not been founded. There